Ultrasound sonication with microbubbles disrupts blood vessels and enhances tumor treatments of anticancer nanodrug
Journal
International Journal of Nanomedicine
Journal Volume
7
Pages
2143-2152
Date Issued
2012
Author(s)
Abstract
Ultrasound (US) sonication with microbubbles (MBs) has the potential to disrupt blood vessels and enhance the delivery of drugs into the sonicated tissues. In this study, mouse ear tumors were employed to investigate the therapeutic effects of US, MBs, and pegylated liposomal doxorubicin (PLD) on tumors. Tumors started to receive treatments when they grew up to about 15 mm3 (early stage) with injection of PLD 10 mg/kg, or up to 50 mm3 (medium stage) with PLD 6 (or 4) mg/kg. Experiments included the control, PLD alone, PLD + MBs + US, US alone, and MBs + US groups. The procedure for the PLD + MBs + US group was that PLD was injected first, MB (SonoVue) injection followed, and then US was immediately sonicated on the tumor. The results showed that: (1) US sonication with MBs was always able to produce a further hindrance to tumor growth for both early and medium-stage tumors; (2) for the medium-stage tumors, 6 mg/kg PLD alone was able to inhibit their growth, while it did not work for 4 mg/kg PLD alone; (3) with the application of MBs + US, 4 mg/kg PLD was able to inhibit the growth of medium-stage tumors; (4) for early stage tumors after the first treatment with a high dose of PLD alone (10 mg/kg), the tumor size still increased for several days and then decreased (a biphasic pattern); (5) MBs + US alone was able to hinder the growth of early stage tumors, but unable to hinder that of medium stage tumors. The results of histological examinations and blood perfusion measurements indicated that the application of MBs + US disrupts the tumor blood vessels and enhances the delivery of PLD into tumors to significantly inhibit tumor growth. ? 2012 Lin et al, publisher and licensee Dove Medical Press Ltd.
SDGs
Other Subjects
doxorubicin; antineoplastic agent; doxorubicin; drug carrier; drug derivative; macrogol derivative; nanomaterial; animal cell; animal experiment; animal model; animal tissue; article; cancer inhibition; cancer staging; cell viability; controlled study; dose response; drug delivery system; drug dose comparison; drug effect; drug megadose; ear tumor; histopathology; low drug dose; male; microbubble; mouse; nanopharmaceutics; nonhuman; tumor blood flow; tumor vascularization; tumor volume; ultrasound; adenocarcinoma; animal; Bagg albino mouse; colorectal tumor; microbubble; multimodality cancer therapy; nanomedicine; pathology; ultrasound therapy; vascularization; Adenocarcinoma; Animals; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Carriers; Male; Mice; Mice, Inbred BALB C; Microbubbles; Nanomedicine; Nanostructures; Polyethylene Glycols; Ultrasonic Therapy
Type
journal article